Recalls / Active ingredient / Dexamethasone
Dexamethasone
5 FDA drug recalls involving the active ingredient “Dexamethasone”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2025-08-13 | Class II | Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension Rx Only, For Use in Ears Only, Manufactured By: Nova | Sandoz Inc |
| 2022-04-13 | Class II | TobraDex (tobramycin and dexamethasone), Ophthalmic Ointment, 3.5 gm, Rx only, Manufacturer: Novartis, NDC 007 | Mckesson Medical-Surgical Inc. Corporate Office |
| 2022-04-13 | Class II | Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment, 3.5 g tube, Rx only MFG: Sandoz, NDC | Mckesson Medical-Surgical Inc. Corporate Office |
| 2019-10-17 | Class III | Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension, Rx Only, Sterile, 5 mL bottle, Manu | Sandoz Inc |
| 2018-12-20 | Class II | OZURDEX (dexamethasone intravitreal implant) 0.7 mg), 1 single-use plastic applicator contained within carton, | Allergan, PLC. |